Status:
COMPLETED
Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance
Lead Sponsor:
Institut Claudius Regaud
Collaborating Sponsors:
Cancer Research Center of Toulouse
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study team previously shown that a cholesterol metabolite, dendrogenin A (DDA) differentiates anaplastic thyroid cancer cell lines and that its mRNA expression is diminished in human radioiodine r...
Detailed Description
Retrospective study to analyze tissue samples of patients after thyroid surgery at Claudius Regaud Institute Toulouse, France, for thyroid cancer or thyroid aggressive lymphoma or benign thyroid patho...
Eligibility Criteria
Inclusion
- Patients who have undergone surgery at Institut Claudius Regaud for thyroid or laryngeal cancer confirmed by histology.
- Patients who have consented before surgery, for the use of participants samples for future researches.
Exclusion
- None
Key Trial Info
Start Date :
April 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04821336
Start Date
April 15 2021
End Date
December 31 2022
Last Update
May 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Claudius regaud IUCT Oncopole
Toulouse, France, 31059